Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease

Anesthesiology

Volumn 84, Issue 4, 1996, Pages 812-820

  Dershwitz, Mark ^a   Hoke, J Frank ^b   Rosow, Carl E ^a   Michałowski, Piotr ^a   Connors, Patricia M ^a   Muir, Keith T ^b   Dienstag, Jules L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Analgesics, opioids: GR90291; remifentanil; Anesthetics, intravenous: remifentanil; Liver: disease; Pharmacodynamics; Pharmacokinetics

Indexed keywords

MU OPIATE RECEPTOR; REMIFENTANIL;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; DOSE LIVER FUNCTION RELATION; DOSE RESPONSE; DRUG CLEARANCE; DRUG RECEPTOR BINDING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG MINUTE VOLUME; MALE; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RISK ASSESSMENT;

ADULT; ANALGESICS, OPIOID; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PIPERIDINES;

EID: 0029867110     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199604000-00008     Document Type: Article

References (17)

1. Egan TD, Lemmens HJM, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL: The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. ANESTHESIOLOGY 1993; 79:881-92
2. Glass PSA, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH, Grosse CM, Hermann D: Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B). Anesth Analg 1993; 77:1031-40
3. Westmoreland CL, Hoke JF, Sebel PS, Hug CC, Muir KT: Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. ANESTHESIOLOGY 1993; 79:893-903
4. Cunningham FE, Hoke JF, Muir KT, James MK, Hoffman WE: Pharmacokinetic/pharmacodynamic evaluation of remifentanil, GR90291, and alfentanil (abstract). ANESTHESIOLOGY 1995; 83:A376
5. Dershwitz M, Randel GI, Rosow CE, Fragen RJ, Connors PM, Librojo ES, Shaw DL, Peng AW, Jamerson BD: Initial clinical experience with remifentanil, a new opioid metabolized by esterases. Anesth Analg 1995; 81:619-23
6. Chauvin M, Ferrier C, Haberer JP, Spielvogel C, Lebrault C, Levron JC, Duvaldestin P: Sufentanil pharmacokinetics in patients with cirrhosis. Anesth Analg 1989; 68:1-4
7. Haberer JP, Schoeffler E, Couderc E, Duvaldestin P: Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis. Br J Anaesth 1982; 14:1267-70
8. Ferrier C, Marty J, Boudard Y, Haberer JP, Levron JC, Duvaldestin P: Alfentanil pharmacokinetics in patients with cirrhosis. ANESTHESIOLOGY 1985; 62:480-4
9. Buchi KN, Rollins, DE, Tolman KG, Achair R, Drissel D, Hulse JD: Pharmacokinetics of esmolol in hepatic disease. J Clin Pharmacol 1987; 27:880-4
10. Jenkins JS, Valcke CP, Ward DS: A programmable system for acquisition and reduction of respiratory physiologic data. Ann Biomed Eng 1989; 17:93-108
11. Dershwitz M, Di Biase PM, Rosow CE, Wilson RS, Sanderson PE, Joslyn AF: Ondansetron does not affect alfentanil-induced ventilatory depression or sedation. ANESTHESIOLOGY 1992; 77:447-52
12. Grosse CM, Davis IM, Arrendale RF, Jersey J, Amin J: Determination of remifemanil in human blood by liquid-liquid extraction and capillary GC/HRMS/SIM using a deuterated internal standard. J Pharm Biomed Anal 1994; 12:195-203
13. Lessard D, Comeau B, Charlebois A, Letarte L, Davis IM: Quantification of GR90291 in human blood by high resolution gas chromatography/mass selective detection (HRGC/MSD). J Pharm Biomed Anal 1994; 12:659-65
14. Dershwitz M, Rosow CE, Di Biase PM, Zaslavsky A: Comparison of the sedative effects of butorphanol and midazolam. ANESTHESIOLOGY 1991; 74:717-24
15. Yamaoka K, Nakagawa T, Uno T: Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokin Biopharm 1978; 6:165-75
16. Gibaldi M, Perrier D: Pharmacokinetics. 2nd edition. New York, Marcel Dekker, 1982, p 345
17. Ausems ME, Hug CC, Stanski DR, Burm AG: Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. ANESTHESIOLOGY 1986; 65:362-73